Gubra A/S (DK0062266474) — research page
DK · dk-cm-kg/XCSE/DK0062266474 · as of 2026-11-06
Identity and listing
The issuer is Gubra A/S, listed on Nasdaq Copenhagen under ticker DK0062266474, with ISIN DK0062266474 and LEI 254900T17RRFZONO6W53. The security type, segment, sector and jurisdiction are not on the record. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Gubra A/S | source · 2026-11-06 |
| exchange | Nasdaq Copenhagen | source · 2026-11-06 |
| ticker | DK0062266474 | source · 2026-11-06 |
| ISIN | DK0062266474 | source · 2026-11-06 |
| LEI | 254900T17RRFZONO6W53 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 46 filings in the twelve months to 2026-11-06, across 40 filing days. The median gap between filing days is 6 days. The latest filing is dated 2026-11-06 and is an Interim report (Q1 and Q3), with 0 days from the latest filing to the record date. Nasdaq Copenhagen holds 119 issuers with a median of 25 filings, a median cadence gap of 8.0 days and a median latency of 4.0 days. The sector median is not on the record for this market.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 46 | 6 | 0 |
| exchange median: Nasdaq Copenhagen (119 issuers) | 25 | 8 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Trading statement Q3 2026 - Significant R&D pipeline advancement and solid CRO performance |
| 2026-10-27 | Investor News | Investor News | Gubra outlines 2030 strategy to scale innovation and expand its clinical-stage pipeline |
| 2026-10-21 | Investor News | Investor News | REMINDER: Gubra Investor R&D Event on October 27, 2026 |
| 2026-09-30 | Investor News | Investor News | Gubra's partner AbbVie presents detailed Phase 1 data for ABBV-295, a long-acting amylin analog, demonstrating favorable tolerability and pharmacokinetic profile at EASD 2026 |
| 2026-09-17 | Investor News | Investor News | Gubra collaboration partner Hemab announces first participant dosed in Phase 1 clinical trial of HMB-003, an investigational therapy for the management of heavy menstrual bleeding |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move entries, because no lifecycle type map is held for this register. The issuer is listed and not halted.
Orderability
The outcome is not determinable under the rule version acm-68000/dk/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/dk/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page as read.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage for this market is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.dk-cm-kg.ai/events/XCSE/DK0062266474 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=exchangeNewsFilterCPH|FirstNorthInformationCPH (the halt flag)
- 10.5
- https://dk.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://mcp.dk-cm-kg.ai/record/XCSE/DK0062266474 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"DK0062266474"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a9275b67172668ff.